C12N 2710/12034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2710/12034 (Use of virus or viral component as vaccine) appears on 21 US grants and 53 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 53
- Assignees
- 41
- Inventors
- 181
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 3 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 3 |
| 2021 | 2 | 3 |
| 2022 | 1 | 12 |
| 2023 | 4 | 11 |
| 2024 | 2 | 7 |
| 2025 | 3 | 6 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant adenovirus expressing African swine fever virus EP153R-EP402R protein and construction method thereof5 May 2026US 12,618,083 B2Institute of Animal Sciences of Chinese Academy of Agricultural Sciences
- Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells21 Apr 2026US 12,606,803 B2
- African swine fever virus chimeric protein, vaccine composition, preparation method and use thereof17 Feb 2026US 12,551,545 B2Pulike Biological Engineering, Inc.
- African swine fever virus vaccine4 Nov 2025US 12,458,690 B2Stichting Wageningen Research
- Viral vector delivery system for both respiratory and digestive tracts of pigs and application thereof26 Aug 2025US 12,397,049 B2Guotai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou
- Vaccines against african swine fever virus, and methods of using same8 Oct 2026US 2026/0306608 A1The Wistar Institute of Anatomy and Biology
- A vaccine for protecting a pregnant swine against african swine fever3 Sep 2026US 2026/0256902 A1Intervet Inc.
- Seven-component antigen african swine fever subunit vaccine7 May 2026US 2026/0124289 A1Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Dual-promoter recombinant vector expressing immunogenic protein of african swine fever virus (asfv), recombinant bacterium, and use thereof11 Dec 2025US 2025/0375513 A1Changsha Lvye Biotechnology Co., Ltd.
- Pathogen-like antigen-based vaccine and preparation method therefor2 Oct 2025US 2025/0302940 A1Institute of Biophysics, Chinese Academy of Sciences
Most cited
By later US patents
- Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate5US 9,808,520 B1The United States of America as represented by the Secretary of Agriculture · 2017
- African swine fever virus georgia strain adapted to efficiently grow in the vero cell line3US 9,474,797 B1The United States of America as represented by the Secretary of Agriculture · 2016
- Attenuated African swine fever virus vaccine1US 10,507,237 B2The Pirbright Institute · 2019
- Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L1US 11,007,263 B2The United States of America as represented by the Secretary of Agriculture · 2021
- Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods1US 11,130,787 B2MBF Therapeutics, Inc. · 2021